These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28443195)

  • 1. Synthesis, quality control and determination of metallic impurities in
    Kilian K; Chabecki B; Kiec J; Kunka A; Panas B; Wójcik M; Pękal A
    Rep Pract Oncol Radiother; 2014 May; 19(Suppl):S22-S31. PubMed ID: 28443195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of radionuclide impurities in [
    Chiappiniello A; Iacco M; Rongoni A; Susta F; Sabatini P; Beneventi S; Tarducci R
    Phys Med; 2020 Oct; 78():150-155. PubMed ID: 33035926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radionuclidic purity tests in (18)F radiopharmaceutIcals production process.
    Dziel T; Tymiński Z; Sobczyk K; Walęcka-Mazur A; Kozanecki P
    Appl Radiat Isot; 2016 Mar; 109():242-246. PubMed ID: 26553157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of radionuclidic impurities in 2-[18F]fluoro-2-deoxy-d-glucose ([18F]FDG) routine production.
    Marengo M; Lodi F; Magi S; Cicoria G; Pancaldi D; Boschi S
    Appl Radiat Isot; 2008 Mar; 66(3):295-302. PubMed ID: 17996453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of F-FDG Synthesis and Quality Control.
    Yu S
    Biomed Imaging Interv J; 2006 Oct; 2(4):e57. PubMed ID: 21614337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of radionuclidic impurities in cyclotron produced (99m)Tc.
    Lebeda O; van Lier EJ; Štursa J; Ráliš J; Zyuzin A
    Nucl Med Biol; 2012 Nov; 39(8):1286-91. PubMed ID: 22796396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impurities in Tc-99m radiopharmaceutical solution obtained from Mo-100 in cyclotron.
    Tymiński Z; Saganowski P; Kołakowska E; Listkowska A; Ziemek T; Cacko D; Dziel T
    Appl Radiat Isot; 2018 Apr; 134():85-88. PubMed ID: 29107513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of radionuclides and radiochemical impurities produced by in-house cyclotron irradiation and subsequent radiosynthesis of PET tracers.
    Ishiwata K; Hayashi K; Sakai M; Kawauchi S; Hasegawa H; Toyohara J
    Ann Nucl Med; 2017 Jan; 31(1):84-92. PubMed ID: 27744544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fast and simple dose-calibrator-based quality control test for the radionuclidic purity of cyclotron-produced (99m)Tc.
    Tanguay J; Hou X; Esquinas P; Vuckovic M; Buckley K; Schaffer P; Bénard F; Ruth TJ; Celler A
    Phys Med Biol; 2015 Nov; 60(21):8229-47. PubMed ID: 26449791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioisotopic Purity of Sodium Pertechnetate 99mTc Produced with a Medium-Energy Cyclotron: Implications for Internal Radiation Dose, Image Quality, and Release Specifications.
    Selivanova SV; Lavallée É; Senta H; Caouette L; Sader JA; van Lier EJ; Zyuzin A; van Lier JE; Guérin B; Turcotte É; Lecomte R
    J Nucl Med; 2015 Oct; 56(10):1600-8. PubMed ID: 26205300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radionuclide impurities in [¹⁸F]F⁻ and [¹⁸F]FDG for positron emission tomography.
    Köhler M; Degering D; Zessin J; Füchtner F; Konheiser J
    Appl Radiat Isot; 2013 Nov; 81():268-71. PubMed ID: 23608142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of Metallic Impurities in Carbon Nanotubes by Glow Discharge Mass Spectrometry.
    Grinberg P; Methven BAJ; Swider K; Mester Z
    ACS Omega; 2021 Sep; 6(35):22717-22725. PubMed ID: 34514243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generator breakthrough and radionuclidic purification in automated synthesis of 68Ga-DOTANOC.
    Belosi F; Cicoria G; Lodi F; Malizia C; Fanti S; Boschi S; Marengo M
    Curr Radiopharm; 2013 Jun; 6(2):72-7. PubMed ID: 23808765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radionuclide impurities in proton-irradiated [18O]H2O for the production of 18F-: activities and distribution in the [18F]FDG synthesis process.
    Bowden L; Vintró LL; Mitchell PI; O'Donnell RG; Seymour AM; Duffy GJ
    Appl Radiat Isot; 2009 Feb; 67(2):248-55. PubMed ID: 19111472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of
    Długosz-Lisiecka M; Jakubowska T; Zbrojewska M
    Appl Radiat Isot; 2019 May; 147():48-53. PubMed ID: 30798205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of Ultra-trace Metal Impurities in High-purity Cadmium Using Inductively Coupled Plasma Mass Spectrometry after Matrix Separation with Anion Exchange Resin.
    Wada A; Nonose N; Ohata M; Miura T
    Anal Sci; 2017; 33(3):357-363. PubMed ID: 28302978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of radionuclidic impurities of (210)Po produced via neutron irradiation of (209)Bi for use in targeted alpha-particle radiotherapy.
    Schultz MK; Borgman MP; Coleman T; Bakhlanov S; Marchenkov N; Line BR
    Appl Radiat Isot; 2007 Jul; 65(7):784-92. PubMed ID: 17466524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convenient and Efficient Method for Quality Control Analysis of 18F-Fluorocholine: For a Small Scale GMP-based Radiopharmaceuticals Laboratory Set-up.
    Hassan H; Abu Bakar S; Halim KN; Idris J; Nordin AJ
    Curr Radiopharm; 2016; 9(2):128-36. PubMed ID: 26013570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution two-dimensional liquid chromatography analysis of key linker drug intermediate used in antibody drug conjugates.
    Venkatramani CJ; Huang SR; Al-Sayah M; Patel I; Wigman L
    J Chromatogr A; 2017 Oct; 1521():63-72. PubMed ID: 28942996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability evaluation of (18)F-FDG at high radioactive concentrations.
    Walters LR; Martin KJ; Jacobson MS; Hung JC; Mosman EA
    J Nucl Med Technol; 2012 Mar; 40(1):52-6. PubMed ID: 22315438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.